TP53 and head and neck squamous cell carcinoma: For example, while we only covered 68% of the TP53 coding region (including most of the DNA-binding region), the mutation frequency and spectrum of TP53 observed in our study were in line with those reported in the TCGA HNSCC dataset [10].